(Eagle News)–The Food and Drug Administration is set to shorten the period of review and approval of applications of generic drugs from 120 days to only 45 days. FDA Director General Samual Zacate made the revelation in a Palace briefing on Tuesday, Feb. 13, after a sectoral meeting with President Bongbong Marcos. According to Zacate, it was “only a matter of time” before he signs the memorandum circular for the ease of the Facilitated Review […]